About International Outreach
The mission of St. Jude’s International Outreach Program (IOP) is to improve the survival rates of children with cancer and other catastrophic diseases worldwide. The IOP accomplishes this by sharing knowledge, technology and organizational skills, implementing new approaches to treat pediatric cancer globally, and generating international networks committed to eradicating cancer in children.
The International Outreach Program works with its partners to:
- Develop evidence-based protocols tailored to regional needs and resources
- Train doctors, nurses, and other healthcare professionals in clinical care best practices
- Improve clinical care and outcomes through increased quality, capacity, and capability of diagnostic pathology and clinical laboratory medicine
- Reduce infection rates by implementing more effective infection prevention, control, and care measures
- Implement institutional pediatric cancer registries and data management best practices to understand the regional burden of pediatric cancer and to help determine which treatments are most effective
These initiatives are spearheaded by St. Jude experts who work closely with healthcare professionals at our partner sites.
Additionally, ALSAC collaborates with partners’ affiliated pediatric cancer foundations to improve local fundraising efforts and advocacy for pediatric cancer treatment.
Select Success Stories
- El Salvador: Increased survival rate for children with acute lymphoblastic leukemia (ALL), the most common childhood cancer, from about 5% in 1993 to 48% in 2000
- Brazil (Recife): Increased survival rate for children with ALL from 32% in the 1980s to 63% in 2002
- China: Demonstrated success in outcomes using low-cost treatment for children with ALL supported policy changes at the governmental level to incorporate increased funding of treatment for children with cancer where there had been little before
- Honduras (Tegucigalpa): Early detection campaigns for retinoblastoma led to a reduction in late diagnoses of the disease from 73% to 35%
- Lebanon: Development of a regional pediatric hematology-oncology network to enhance cancer care for all children in the Middle East
- Morocco (Rabat): Increased survival rate for children with Hodgkin lymphoma from 43% in 2000 to 70% in 2013